Try our Advanced Search for more refined results

Deals Rumor Mill: Pfizer, Sprint, AT&T

By Karlee Weinmann (May 1, 2014, 4:28 PM EDT) -- Pharma powerhouse Pfizer Inc. could increase its bid for British rival AstraZeneca PLC to $106 billion, including a greater cash consideration, sources told Bloomberg on Thursday. The revised bid could come as soon as next week. New York-based Pfizer said earlier this week that it had already twice approached AstraZeneca with takeover bids but had met with rejection both times. For its part, AstraZeneca said the strategy it has in place has yielded strong results — though it suggested it would be open to a sweetened Pfizer proposal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!